Home > Insider Trading > Merck Sharp & Dohme Corp. > Profile

Merck Sharp & Dohme Corp. (MRK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Sector: Pharmaceutical Preparations

Related Insiders

E Carlos Represas, Director, 2011-01-20
T Richard Clark, Officer, Director, 2009-11-04
S Peter Kim, Officer, 2009-11-04

E Carlos Represas, Director, 2011-01-20
T Richard Clark, Officer, Director, 2009-11-04
S Peter Kim, Officer, 2009-11-04
A Celia Colbert, Officer, 2009-11-04
John Canan, Officer, 2009-11-04
C Kenneth Frazier, Officer, 2009-11-04
N Bruce Kuhlik, Officer, 2009-11-04
Stefan Oschmann, Officer, 2009-11-04
A Willie Deese, Officer, 2009-11-04
M Mirian Weir Graddick, Officer, 2009-11-04
Chris J Scalet, Officer, 2009-11-04
E Mark Mcdonough, Officer, 2009-11-04
H Adam Schechter, Officer, 2009-11-04
P Wendell Weeks, Director, 2009-11-04
C Peter Wendell, Director, 2009-11-04
Md O Samuel Thier, Director, 2009-11-04
M Anne Tatlock, Director, 2009-11-04
E Thomas Shenk, Director, 2009-11-04
B Rochelle Lazarus, Director, 2009-11-04
N Willam Kelley, Director, 2009-11-04
R Harry Jacobson, Director, 2009-11-04
Jr B William Harrison, Director, 2009-11-04
F Steven Goldstone, Director, 2009-11-04
H Thomas Glocer, Director, 2009-11-04
R Thomas Cech, Director, 2009-11-04
A Leslie Brun, Director, 2009-11-04
G Margaret Mcglynn, Officer, 2009-04-27

Show All Insiders (27)

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Kelley	$33.22	550	Director	750	2006-01-18	Filing
Kelley	$45.65	200	Director	200	2002-09-24	Filing

News See All

10 Most Promising Cancer Stocks According to Hedge Funds

According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in six deaths worldwide.

Keep Reading →

November 22nd, 2024 - Hedge Funds Industries News

8 Most Promising Healthcare Stocks According to Hedge Funds

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.

Keep Reading →

November 21st, 2024 - News Stock Analysis

Goldman Sachs' Top Growth Investors: 34 Stocks With The Highest Investment For Growth

With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle, and an economy with lower...

Keep Reading →

November 20th, 2024 - News

Ken Griffin Stock Portfolio: 10 Stocks to Buy

Ken Griffin, the visionary founder of Citadel Investment Group, launched his hedge fund in 1990 with $4.2 million, achieving unprecedented success.

Keep Reading →

November 19th, 2024 - Hedge Funds News

Jim Cramer Talked About These 11 Stocks Recently

On Thursday, Jim Cramer, host of Mad Money, discussed the current state of the market following the election, noting that it has been marked by extreme volatility, with some sectors experiencing massive...

Keep Reading →

November 18th, 2024 - Hedge Funds News

10 Best Immunotherapy Stocks to Buy Now

The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.

Keep Reading →

November 18th, 2024 - Hedge Funds News

10 Best Low Volatility Stocks to Invest in Now

The first week of November has been quite eventful so far.

Keep Reading →

November 8th, 2024 - Hedge Funds News

UBS' Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks

The stock market at the tail end of 2024 is an evolution of the patterns we've observed since the start of the coronavirus pandemic.

Keep Reading →

November 5th, 2024 - Market Movers News

10 Best Pharma Stocks To Buy Right Now

Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design...

Keep Reading →

November 4th, 2024 - Hedge Funds Industries News